632 results for:
New milestone reached for neuroprotective drug developed in WA
Post
A neuroprotective drug developed in Western Australia has been granted Rare Pediatric Disease Designation (RPDD) by the U.S. Food and Drug Administration for the treatment of hypoxic ischaemic encephalopathy (HIE) in newborn term infants. HIE is a form of brain...
Spotlight on Petrina Keating – MS Specialist Research Nurse
Post
Being able to help people with multiple sclerosis (MS) and hopefully improve their day is something that inspires Perron Institute MS Specialist Research Nurse Petrina Keating. “I completed my Nursing Degree in Ireland over 20 years ago and began working...
WA researchers awarded funding to fuel future NHMRC success
Post
A total of $4.73 million in funding has been awarded to 25 early and mid-career researchers under the Future Health Research and Innovation (FHRI) Fund WA Near Miss Awards: Emerging Leaders 2023 (WANMA EL) program. The WANMA EL program is...
Finding new biological markers for MS a focus for Dr Xiaonan Zhong MD PhD
Post
Finding new biological markers for multiple sclerosis (MS) and other diseases remains a goal for Dr Xiaonan Zhong, MD and PhD. Recently, she was awarded her PhD by The University of Western Australia. is part of the at the Perron...
New funding to advance innovative multiple sclerosis research
Post
WA researchers hope to gain new insights into the way immune cells in the body trigger attacks of multiple sclerosis (MS), thanks to new funding from MS Australia. MS is a debilitating and progressive condition where a person’s immune system...
WA researchers contribute to rare disease biomarker discovery
Post
Recently published research on a rare autoimmune disorder that shares symptoms with multiple sclerosis (MS) has provided the first potential biomarker to predict disease prognosis. Researchers from Western Australia’s Perron Institute have contributed to this investigation of an inflammatory disease...
Potential treatment hope for Angelman syndrome supported by a Telethon grant
Post
The initial development of a novel drug treatment for children living with rare genetic diseases including Angelman syndrome has been supported by a Channel 7 Telethon Trust grant. The research focuses on three imprinting disorders (congenital conditions) associated with faulty...
Perron Institute Bridges Fun Run For Youth Mental Health
Post
Perron Institute Bridges Fun Run For Youth Mental Health When: Sunday 14th April 2024 Where: Barrack Square, Perth Perron Institute has teamed up with West Australian Marathon Club (WAMC) for the Perron Institute Bridges Fun Run for Youth Mental...
Spotlight on Ruby Shehatha – Clinical Research Assistant
Post
From an early age, Ruby Shehatha knew she would work in the medical field. Her father is a surgeon and she thought dentistry would be her career pathway. “It was during my Bachelor of Science in Anatomy and Human Biology...
Aleksandra Miljevic
Researcher
Aleks is an Early Career Researcher within the Research Group lead by . She has clinical trial experience in mental health populations and as a result of her PhD, where she conducted innovative research in individuals with depression investigating the...
WA TMS Network
Focus Area
The aim of the WA TMS Network is to build a research network of clinicians and service providers to create and undertake research in a collaborative environment to improve the care and wellbeing of West Australians. The WA TMS Network...